As investors await the opening of Anthem Biosciences IPO, here are the key strengths and risks outlined in its Red Herring ...

On the financial front, Anthem reported a net profit of ₹451.3 crore for the financial year ended March 2025, up 22.9% from ...

We’re now the second source for many products made in China—and the first choice for new ones,” Ajay Bhardwaj, CEO and Founder of Anthem told Moneycontrol in an interview.

Mumbai: Asston Pharmaceuticals Limited has launched its Rs 27.56 crore IPO, open for subscription from July 9 to 11. With a ...

Anthem Biosciences is preparing to launch its Rs 3,395-crore IPO on July 14, entirely an offer-for-sale by selling ...

Shares of Anthem Biosciences are quoting a premium of more than 12 percent over the IPO price in the grey market.

Anthem Biosciences will open its ₹3,395 crore initial public offering (IPO) for public subscription on July 14. The three-day issue will close on July 16, while bids from anchor investors will ...

Anthem Biosciences IPO is scheduled to run from July 14 to July 16, with the anchor book slated to open on July 11. Anthem ...

Anthem Biosciences IPO priced at ₹530-₹570, valued at ₹31,800 crore, with no funds going to the company.

Anthem Biosciences has set a price band of Rs 530-570 for its Rs 3,395-crore IPO. Scheduled for July 14-16, the offering is ...

India’s derivatives boom is a remarkable story of financial inclusion and technological scale. But scale alone isn’t a ...